LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,199,561 | -22.0% | 162,555 | -1.2% | 0.01% | -16.7% |
| Q1 2024 | $9,230,900 | -6.0% | 164,573 | +0.9% | 0.01% | -14.3% |
| Q4 2023 | $9,815,532 | +3.8% | 163,130 | +15.9% | 0.01% | -12.5% |
| Q3 2023 | $9,454,446 | -4.3% | 140,754 | -1.6% | 0.01% | 0.0% |
| Q2 2023 | $9,878,400 | +47.2% | 143,103 | +2.8% | 0.01% | +60.0% |
| Q1 2023 | $6,710,102 | +12.8% | 139,156 | +16.8% | 0.01% | 0.0% |
| Q4 2022 | $5,949,016 | +31.2% | 119,171 | +7.2% | 0.01% | +25.0% |
| Q3 2022 | $4,534,000 | -19.6% | 111,128 | +8.4% | 0.00% | 0.0% |
| Q2 2022 | $5,638,000 | +58.5% | 102,516 | +4.7% | 0.00% | +100.0% |
| Q1 2022 | $3,558,000 | +2.1% | 97,903 | +30.9% | 0.00% | 0.0% |
| Q4 2021 | $3,486,000 | – | 74,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 372,989 | $10,824,000 | 8.53% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $47,279,000 | 6.12% |
| Vivo Capital, LLC | 2,755,007 | $79,950,000 | 2.81% |
| Consonance Capital Management LP | 896,608 | $26,020,000 | 2.77% |
| Yong Rong (HK) Asset Management Ltd | 198,312 | $5,756,000 | 1.58% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,054,242 | $30,594,000 | 1.28% |
| Hudson Bay Capital Management LP | 2,167,274 | $62,894,000 | 0.78% |
| Capital International, Inc./CA/ | 1,916,845 | $55,627,000 | 0.52% |
| Capital International Sarl | 172,546 | $5,007,000 | 0.48% |
| Novo Holdings A/S | 254,176 | $7,376,000 | 0.30% |